Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-23

Clinical Trial Update: Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and drug levels of an Exenatide implant for overweight/obesity and type 2 diabetes; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exenatide implant (exenatide)

Snippet

Sponsor: Vivani Medical, Inc | Conditions: Overweight and Obesity, Type2diabetes | Phase 1 | Status: COMPLETED